Article
Neuroprotective effects of Canagliflozin: lessons from aged genetically diverse UM-HET3 mice
2022-01-28
Abstract excerpt
The aging brain is characterized by a progressive increase in neuroinflammation and central insulin resistance, which contribute to neurodegenerative diseases and cognitive impairment. Recently, the Interventions Testing Program (ITP) demonstrated that the anti-diabetes drug, Canagliflozin (Cana), a sodium-glucose transporter 2 inhibitor (SGLT2i), led to lower fasting glucose and improved glucose tolerance in both...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5f6e1a73-8822-550d-92b2-db2787d9be5b
- DOI
- 10.1101/2022.01.27.478017
